• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Introduction to 2-fluoro-6-(3-phenylmethoxyphenyl)benzoic Acid (CAS No. 1261979-60-5)

2-fluoro-6-(3-phenylmethoxyphenyl)benzoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 1261979-60-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the class of benzoic acid derivatives, characterized by its structural complexity and potential biological activity. The presence of both a fluorine atom and a phenylmethoxy group in its molecular framework imparts unique electronic and steric properties, making it a valuable scaffold for the development of novel therapeutic agents.

The molecular structure of 2-fluoro-6-(3-phenylmethoxyphenyl)benzoic acid consists of a benzoic acid core substituted at the 2-position with a fluorine atom and at the 6-position with a 3-phenylmethoxyphenyl group. This arrangement creates a molecule with multiple sites for interaction with biological targets, including enzymes and receptors. The fluorine atom, in particular, is known to enhance metabolic stability and binding affinity, while the phenylmethoxy group contributes to lipophilicity and solubility characteristics that are often desirable in drug candidates.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors for various therapeutic targets. 2-fluoro-6-(3-phenylmethoxyphenyl)benzoic acid has emerged as a promising lead compound in this endeavor due to its ability to modulate key biological pathways. Studies have demonstrated its potential in inhibiting enzymes involved in inflammation, pain perception, and metabolic disorders. The compound’s unique structural features allow it to interact selectively with target proteins, minimizing off-target effects and improving overall efficacy.

One of the most compelling aspects of 2-fluoro-6-(3-phenylmethoxyphenyl)benzoic acid is its versatility in medicinal chemistry applications. Researchers have leveraged its scaffold to design derivatives with enhanced pharmacokinetic profiles and improved therapeutic outcomes. For instance, modifications at the 3-position of the phenylmethoxy group have been explored to optimize solubility and bioavailability. Additionally, the fluorine atom has been strategically positioned to enhance binding interactions with heme-containing enzymes, such as cyclooxygenases (COX) and lipoxygenases (LOX), which are critical mediators of inflammatory responses.

The pharmacological profile of 2-fluoro-6-(3-phenylmethoxyphenyl)benzoic acid has been extensively evaluated in preclinical studies. These investigations have revealed its potential as an anti-inflammatory agent, with demonstrated efficacy in animal models of acute and chronic inflammation. Furthermore, preliminary data suggest that it may exhibit analgesic properties by modulating pain signaling pathways. The compound’s ability to interact with multiple targets makes it an attractive candidate for developing combination therapies that address complex diseases.

Advances in computational chemistry and structure-based drug design have further accelerated the development of 2-fluoro-6-(3-phenylmethoxyphenyl)benzoic acid derivatives. Molecular docking studies have identified key interactions between this compound and its target proteins, providing insights into its mechanism of action. These findings have guided the rational design of next-generation analogs with improved potency and selectivity. Additionally, high-throughput screening (HTS) techniques have been employed to identify novel scaffolds based on the 2-fluoro-6-(3-phenylmethoxyphenyl)benzoic acid core, expanding the chemical space for drug discovery.

The synthesis of 2-fluoro-6-(3-phenylmethoxyphenyl)benzoic acid presents unique challenges due to its complex structure. However, advancements in synthetic methodologies have made it more accessible for research purposes. Multi-step synthetic routes involving palladium-catalyzed cross-coupling reactions and fluorination techniques have been optimized to achieve high yields and purity. These synthetic strategies not only facilitate the production of the parent compound but also provide a platform for generating libraries of derivatives for further pharmacological evaluation.

In conclusion, 2-fluoro-6-(3-phenylmethoxyphenyl)benzoic acid (CAS No. 1261979-60-5) represents a significant advancement in medicinal chemistry research. Its unique structural features, coupled with promising preclinical data, position it as a valuable tool for developing novel therapeutics targeting inflammation, pain, and metabolic disorders. As research continues to uncover new applications for this compound and its derivatives, it is likely to play an increasingly important role in drug discovery and development efforts worldwide.

• 1183013-63-9(2-fluoro-4-(4-methoxy-2-methylphenyl)benzoic Acid)
• 1261889-97-7(2-(3-fluoro-4-methylphenyl)-5-methoxybenzoic Acid)
• 1261981-29-6(4-(3-Benzyloxyphenyl)-2-fluorobenzoic acid)
• 1261912-52-0(2-(4-Fluoro-3-methoxycarbonylphenyl)-5-methoxybenzoic acid)
• 1261933-96-3(2-(3-fluoro-4-methoxycarbonylphenyl)-5-methoxybenzoic Acid)
• 1261993-50-3(2-(2-fluoro-4-methoxycarbonylphenyl)-5-methoxybenzoic Acid)
• 1261989-40-5(2-[4-(Ethoxycarbonyl)-3-fluorophenyl]-5-methoxybenzoic acid)
• 1261968-51-7(2-(3-ethoxyphenyl)-6-fluorobenzoic Acid)
• 1261932-69-7(2-(3-fluoro-2-methylphenyl)-5-methoxybenzoic Acid)
• 1261915-82-5(2-(2-fluoro-4-methylphenyl)-5-methoxybenzoic Acid)